Insulet Showcases Omnipod Innovations at American Diabetes Association Sessions
Insulet Corporation, a leader in tubeless insulin pump technology, is set to present new data and innovations at the American Diabetes Association's 86th Scientific Sessions in New Orleans. The company will highlight advancements in its Omnipod products, focusing on reducing user effort and improving clinical outcomes for diabetes management. Key presentations will include updates on the Omnipod 5 Automated Insulin Delivery System, featuring a new algorithm designed to enhance time in range and reduce disease burden. Insulet will also discuss findings from the STRIVE trial, which supports the regulatory submission of the next-generation Omnipod 6 system. The event will feature various sessions and presentations by leading diabetes experts, showcasing the company's commitment to patient-centered design and breakthrough algorithm performance. 
